Prestige Consumer Healthcare Inc. PBH
46.61
0.96
2.10%
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 13.0×
Follow PBH
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
11.29% | 10.31% | 10.22% | 9.12% | |
| 5.94% | 5.47% | 5.52% | 4.30% | ||
ROIC |
7.63% | 7.15% | 6.82% | 4.70% | |
Return on Tangible Assets |
46.07% | 44.19% | 44.03% | 37.38% | |
Average Days of Receivables |
65.41 | 62.99 | 64.34 | 61.89 | |
Free Cash Flow per Share |
5.21 | 5.58 | 5.09 | 4.96 | |
Free Cash Flow |
255.45 | 267.19 | 246.45 | 235.36 | |
Capital Expenditures |
(7.98) | (9.45) | (11.18) | (14.04) | |
Piotroski F-Score |
6.00 | 4.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
8.91% | 9.40% | 8.69% | 6.17% | |
Accounts Receivable Turnover |
6.13 | 6.17 | 5.64 | 6.21 | |
Accounts Payable Turnover |
13.34 | 15.51 | 23.64 | 17.39 | |
Inventory Turnover |
3.09 | 3.07 | 3.21 | 2.99 | |
Average Days of Payables |
31.39 | 32.37 | 16.87 | 26.20 | |
Days of Inventory on Hand |
119.04 | 123.29 | 117.79 | 135.22 | |
Tax Rate |
(0.30) | (0.30) | (0.26) | (0.27) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.26% | 23.91% | 24.36% | 25.32% | |
Share Based Compensation of Revenue |
0.99% | 0.99% | 1.00% | 1.01% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.31 | 1.48 | 1.35 | 1.45 | |
Depreciation/Fixed assets |
0.43 | 0.25 | 0.27 | 0.29 | |
Capex/Depreciation |
(0.26) | (0.30) | (0.34) | (0.41) | |
Revenue per Share |
22.65 | 23.05 | 22.47 | 23.28 | |
Operating CF per Share |
5.37 | 5.78 | 5.32 | 5.25 | |
Capex per Share |
(0.16) | (0.20) | (0.23) | (0.30) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
18.09% | 16.90% | 17.48% | 15.57% |
Columns are period end dates